AOLS (Aeolus Pharmaceuticals) Cyclically Adjusted PB Ratio: (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aeolus Pharmaceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aeolus Pharmaceuticals  (OTCPK:AOLS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Aeolus Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms


Aeolus Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Aeolus Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aeolus Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Aeolus Pharmaceuticals Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aeolus Pharmaceuticals Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AOLS vs RDGL, PCYN, YBAO: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aeolus Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aeolus Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aeolus Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aeolus Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Aeolus Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Aeolus Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2017 is calculated as:

For example, Aeolus Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2017 was:

Adj_Book=Book Value per Share/CPI of Jun. 2017 (Change)*Current CPI (Jun. 2017)
=0.001/244.9550*244.9550
=0.001

Current CPI (Jun. 2017) = 244.9550.

Aeolus Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
200709 0.037 208.490 0.043
200712 0.021 210.036 0.024
200803 0.002 213.528 0.002
200806 -0.015 218.815 -0.017
200809 -0.033 218.783 -0.037
200812 -0.033 210.228 -0.038
200903 -0.005 212.709 -0.006
200906 -0.014 215.693 -0.016
200909 -0.031 215.969 -0.035
200912 -0.366 215.949 -0.415
201003 -0.220 217.631 -0.248
201006 -0.314 217.965 -0.353
201009 -0.471 218.439 -0.528
201012 -0.559 219.179 -0.625
201103 -0.463 223.467 -0.508
201106 -0.353 225.722 -0.383
201109 -0.385 226.889 -0.416
201112 -0.332 225.672 -0.360
201203 -0.268 229.392 -0.286
201206 -0.212 229.478 -0.226
201209 -0.324 231.407 -0.343
201212 -0.259 229.601 -0.276
201303 0.012 232.773 0.013
201306 0.008 233.504 0.008
201309 0.005 234.149 0.005
201312 0.002 233.049 0.002
201403 0.000 236.293 0.000
201406 0.012 238.343 0.012
201409 0.012 238.031 0.012
201412 0.008 234.812 0.008
201503 0.003 236.119 0.003
201506 -0.002 238.638 -0.002
201509 -0.006 237.945 -0.006
201512 0.037 236.525 0.038
201603 0.033 238.132 0.034
201606 0.028 241.018 0.028
201609 0.021 241.428 0.021
201612 0.014 241.432 0.014
201703 0.007 243.801 0.007
201706 0.001 244.955 0.001

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aeolus Pharmaceuticals Business Description

Address 26361 Crown Valley Parkway, Suite 150, Mission Viejo, CA, USA, 92691
Aeolus Pharmaceuticals Inc is a Southern California-based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.